Citation Impact
Citing Papers
The Pharmacology of Citalopram Enantiomers: The Antagonism by R‐Citalopram on the Effect of S‐Citalopram*
2006
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
2006
Escitalopram
2005
Major depressive disorder
2016 Standout
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
2005
Depressive disorders—is it time to endorse different pathophysiologies?
2005
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Cushing's syndrome
2015 Standout
Neuroanatomical Studies of Major Affective Disorders
1988
Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial
2008
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients
2014
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Obesity in Patients With Severe Mental Illness
2009
Usefulness of Somatostatin Receptor Scintigraphy in Patients with Occult Ectopic Adrenocorticotropin Syndrome
1999
Cancer mortality in patients with schizophrenia
2009
Industry sponsorship and research outcome
2012 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Hippocampal atrophy in recurrent major depression.
1996 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Tardive Dyskinesia: Reversible and Irreversible
1985
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Citalopram versus other anti-depressive agents for depression
2012
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
1987 Standout
Risperidone versus placebo for schizophrenia
2016
Industry sponsorship and research outcome
2017 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Azorin Jm being referenced
Traitement des épisodes dépressifs sévères : escitalopram est plus efficace que citalopram
2004
Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes
2011
Efficacy of escitalopram in patients with severe depression: a pooled analysis
2005
[Tardive dyskinesia and affective disorders].
1989
Syndrome de Cushing révélateur d'un carcinome neuroendocrine bronchique: intérêt de la scintigraphie à l'octréotide
1997
Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia
2008
Sertindole is well tolerated and superior to risperidone with respect to efficacy in patients with schizophrenia
2003